Back to Search Start Over

Study of potent CDK7 inhibitor secondary metabolites from Tecomella undulata .

Authors :
Khandelwal P
Tiwari H
Sharma V
Mali D
Vyas P
Wadhwani BD
Source :
Natural product research [Nat Prod Res] 2022 Nov; Vol. 36 (22), pp. 5793-5797. Date of Electronic Publication: 2022 Jan 04.
Publication Year :
2022

Abstract

Chemical investigation of the petroleum ether extract of heartwood of Tecomella undulata led to the isolation of tectonaquinone B (1), 2-methylquinizarin (2) along with tecomaquinone I (3), lapachol (4), 2-isopropenylnaphtho[2,3-b]-furan-4,9-quinone (5), dehydro-α-lapachone (6), α-lapachone (7), and β-lapachone (8). This is the first report of isolation of tectonaquinone B and 2-methylquinizarin from this plant. The structures of compounds were elucidated by advanced spectroscopic methods. Molecular docking study for potential inhibitory action toward CDK7 (cyclin-dependent kinase 7) were performed, which proved that these compounds have high binding affinities with the receptor protein (CDK7). 2-Methylquinizarin exhibited best docking score (-7.70 kcal/mol) among all the tested compounds. The present study showed that 2-methylquinizarin may exhibit potent anticancer activity through inhibiting CDK7 via interaction with Met94.

Details

Language :
English
ISSN :
1478-6427
Volume :
36
Issue :
22
Database :
MEDLINE
Journal :
Natural product research
Publication Type :
Academic Journal
Accession number :
36411529
Full Text :
https://doi.org/10.1080/14786419.2021.2016748